Tourmaline Bio, Inc. (TRML) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
27 West 24th Street
New York City, NY 10010
United States of America (the)
Phone
646-481-9832
Sector
Healthcare
Industry
Biotechnology
Employees
74
First IPO Date
May 07, 2021
| Name | Title | Pay | Year Born |
| Sandeep C. Kulkarni | Co-Founder, Chief Executive Officer & Director | 848,250 | 1982 |
| Kevin Johnson | Chief Regulatory Officer | 555,835 | 1965 |
| Ryan Robinson | Chief Financial Officer & Treasurer | 575,855 | 1989 |
| W. Bradford Middlekauff | Chief Business Officer, General Counsel & Corporate Secretary | 582,250 | 1962 |
| John Walsh | Vice President & Head of Medical Affairs | 0 | N/A |
| Don Fitch | Senior Vice President of Product Development | 0 | N/A |
| Gerhard Hagn | Senior Vice President and Head of Commercial & Business Development | 0 | N/A |
| Famina Hemani | Vice President & Head of Pharmacovigilance | 0 | N/A |
| Kimberly Piorkowski | Vice President of People, Culture & Compliance | 0 | N/A |
| Dora Rau | Senior Vice President & Head of Quality | 0 | N/A |
| Emil deGoma | Senior Vice President of Medical Research | 0 | N/A |
| Kristine Erickson | Vice President & TA Head of Ophthalmology, Medical Research | 0 | N/A |
| Susan Dana Jones | Chief Technology Officer | 0 | 1961 |
Tourmaline Bio, Inc. is a clinical-stage biotechnology firm committed to advancing therapies for individuals suffering from debilitating immune disorders. The company's development pipeline focuses on conditions such as Atherosclerotic Cardiovascular Disease (ASCVD) and Thyroid Eye Disease (TED). Established in 2021, this enterprise is headquartered in New York, New York.